Contrast-Enhanced Bladder Tumor Imaging
Join Massimo Alfano, PhD as he discusses a novel platform for bladder tumor imaging.
Brain-Derived Tau in Blood: the Future of Alzheimer’s Disease Diagnosis?
Recently published in Brain, Gonzalez-Ortiz et al. report the design and development of a novel blood-based biomarker specific to brain-derived tau. In this blog post, we dive into the advantages of their novel immunoassay over those that are commercially available, as well as its future implications for Alzheimer’s disease diagnosis.
Extracellular Vesicles as Breast Cancer Biomarkers
Triple-negative breast cancer is particularly aggressive, challenging to treat, and accounts for 15-20% of all breast cancers. In this blog, we review a study published in Nature Communications that examines the transforming growth factor-β targetable signaling pathway, its role in malignant cancer progression and immune suppression, and tumor-derived extracellular vesicles as diagnostic and prognostic biomarkers.
#ExpertAnswers: Bonnie Lun on Single-Domain Antibodies for Research
Dr. Bonnie Lun from Fortis Life Sciences discusses applications and advantages of using nanobodies for diagnostic and therapeutic research, and highlights Fortis/Abcore's single-domain antibody discovery services.
Single-Domain Antibodies: A Promising New Tool for Diagnostic and Therapeutic Research
Dr. Bonnie Lun discusses applications and advantages of using single-domain antibodies for diagnostic and therapeutic research.
#ExpertAnswers: Yuning Chen on Antibody Production
Yuning Chen discusses strategies involved in recombinant antibody production and introduces a novel antibody expression platform to facilitate antibody library generation.
Recombinant Antibody Production: Current Methods and a Novel Antibody Generation Platform
Dr. Yuning Chen discusses strategies involved in recombinant antibody production and introduce a novel antibody expression platform to facilitate antibody library generation.
How Transformative Antibody Technology Can Improve Your Bioanalytical Assays
Dr. Royle discusses how the combination of antibody phage display and SpyTag technologies can generate critical antibody reagents with a difference.
